Tooth loss associated with the use of tenofovir disoproxil fumarate.

WHAT IS KNOWN AND

OBJECTIVE

The frequent tenofovir disoproxil fumarate (TDF)-related adverse drug reactions (ADRs) are nephrotoxicity and bone toxicity; however, tooth-related ADRs of TDF have not been reported. We describe the case of a 41-year-old Han Chinese man with chronic hepatitis B with TDF-associated tooth loss.

CASE SUMMARY: He presented with halitosis, gingival swelling and tooth loss after TDF use. After excluding the possibility of other drug-related ADRs, TDF was considered a possible cause and switched with tenofovir alafenamide fumarate (TAF). After 6 months, the oral symptoms disappeared, with no additional tooth loss.

WHAT IS NEW AND

CONCLUSION

This is the first report of such ADRs. The ADR score was 7, indicating tooth loss as a potential TDF-related ADR.